Retinoblastoma susceptibility gene (Rb) is a tumoursuppressor gene that codes for a nuclear phosphoprotein which plays a key role in cell cycle regulation (Buchkovich et al., 1989; Mihara et al., 1989; Chen et al., 1989) . Although Rb protein is expressed in all the human organs examined, this expression is at heterogeneous levels which seem to be related to the growth and differentiation status of each cell type (Cordon-Cardo and Richon, 1994) .
Rb acts as a signal transducer, connecting the cell cycle clock with transcriptional machinery. Levels of Rb protein are modified during the cell cycle, as well as its phosphorylation state. Rb protein in its hypophosphorylated state works as a negative regulator of the cell cycle by forming complexes with transcription factors such as E2F (Challeppan et al., 1991) . This interaction sequesters E2F, which is known to stimulate the expression of genes required for the S-phase transition. When Rb is phosphorylated by the cyclin/cyclindependent kinase complexes (CDKs), it becomes inactivated and permits the G,/S transition (Lees et al., 1991; Lin et al., 1991) .
Rb is inactivated in many human malignancies and virally induced cell transformations including sarcomas, carcinomas of the bladder, lung, breast, prostate, parathyroid, liver and malignancies of the blood and brain (Lee et al., 1990; Ginsgerg et al., 1991; Horowitz et al., 1990 Horowitz et al., , 1991 Ishikawa et al., 1991; Xu et al., 1991a; Shimizu et al., 1994) . While benign tumours usually express high levels of Rb protein, low or undetectable levels of the protein have been shown in highgrade invasive neoplasias (Ishikawa et al., 1991; Xu et al., 1991a; Kornblau et al., 1994) . These Rb-negative tumours have been shown to follow a more aggressive clinical course (Cance et al., 1990; Xu et al., 1991a; Kornblau et al., 1994; Cordon-Cardo et al., 1992) .
Several viral oncoproteins, such as SV40 T antigen, EIA, HPV-E7 and EBNA-5, bind specifically to hypophosphorylated Rb, resulting in increased proliferation of the infected cells (DeCaprio et al., 1988; Whyte et al., 1988; Dyson et al., 1989; Egan et al., 1989; Slebos et al., 1994; Szekely et al., 1993) Very little is known about the status of Rb in Hodgkin's disease (HD). Previous findings by our group in frozen sections show weak Rb expression of the protein in roughly two-thirds of HD cases studied (Martinez et al., 1993) .
Owing to the role of Rb protein in cell cycle regulation, and the absence of previous studies of Rb expression in HD, we studied its expression in a large group Reed (H and SR) cells has also been included in the study, since both proteins (p53 and Rb) have been found to be closely associated in cell cycle control White 1994) . For this purpose, we made use of heat-induced retrieval antigen techniques, which lower the reactivity threshold in paraffin section immunohistochemistry. The results were analysed using a computerised system for quantifying and comparing results.
Materials and methods Biopsies
A total of 21 paraffin-embedded biopsies from patients with Hodgkin's lymphoma were obtained from the 'Virgen de la Salud' Hospital (Toledo) The simultaneous staining of known Rb-, p53-and Ki67-positive cases were used as positive controls. An internal control for each case was provided by the Ki67 reactivity always present in some reactive lymphocytes. The incubation of parallel slides omitting the first antibody was performed as a negative control.
Quantitative studies Quantitative immunohistochemical investigation with the quantitative nuclear antigen application of the computerised analyser system (CAS 200) was used to score individual nuclei for the presence of Rb and p53 nuclear protein (Martinez et al., 1993) . This program measured the percentage of total optical density of positive cell nuclei in tissue sections, i.e. the intensity of nuclear staining in comparison with total nuclear area (Martinez et al., 1993; Figge et al., 1991; Cance et al., 1990 (Vindelov et al., 1983) .
Results
Non-neoplastic tissues Reactive tonsils and normal peripheral blood lymphocytes were included in the study to establish the normal levels of expression of Rb protein, and its relationship with the proliferation index in non-neoplastic lymphoid tissues.
Reactive tonsil tissue was immunostained with MAbs for the Rb and Ki67 proteins. The nuclei of large germinal centre cells and proliferating cells in the interfollicular area exhibit simultaneous staining for Ki67 and Rb proteins. The relationship between the expression of both proteins (measured by the CAS200 image analyser) was high and statistically significant (r = 0.96, P = 0.038). This parallelism in the expression of both proteins is also observed in tonsilar epithelial suprabasal cells (Figures la and b) .
Western blot (WB) analysis of PHA-stimulated lymphocytes showed an increase in the amount and degree of Rb protein phosphorylation along cell cycle progression ( Figure  2a and Table I (Figure 2b ). Rb/Ki67 and Rb/p53 relationship in HD The existence of an overall relationship between the three parameters (Rb, p53 and Ki67 protein expression) was investigated using Spearman's rank correlation coefficient. Taking all the cases into consideration, Rb was not found to be related to p53 (r=0.288, P=0.001) or Ki67 (r=0.2892, P=0.001) (Table IV and Figure 4a ).
When different histopathological types are taken into consideration, some differences appear: NLP-HD cases show a strong relation between Rb and Ki67 (r = 0.8727, P = 0.000) (Figure 4b and Table IV) . This relationship was not found in the classical forms of HD (NS-HD and MC-HD) (Table IV) .
When the relationship between parameters was analysed according to the percentage of SR cells (Table V) 
Discussion
This study examined the expression of Rb protein in nonneoplastic lymphoid tissue and in a large series of HD cases.
In the attempt to establish Rb protein levels in nonneoplastic lymphoid cells and tissues, its expression was studied in peripheral blood lymphocytes (PBLs) and reactive tonsils. We found that, after PHA stimulation, the amount of (Buchkovich et al., 1989; Chen et al., 1989; Mihara et al., 1989) and other studies showing variation in Rb protein levels in B and T lymphocytes, when cells entered the S-phase in response to mitogens (Martinez et al., 1993; Tereda et al., 1991) . This increase in Rb protein along the cell cycle has also been detected in other cell types (Xu et al., 1991b) , and is also found in this study in reactive tonsils, which show a similar pattern of staining for Rb and Ki67. Rb protein appears to be preferentially expressed in proliferating cells located in germinal centres and suprabasal layers of the epithelium (Martinez et al., 1993; Mateo et al., 1995) .
In the light of this parallel increase of Rb protein levels and Ki67 proliferation index, we studied both parameters in a large number of cases of HD (130). Rb protein immunostaining was found in most cases, distributed mainly in H and SR cells. Although in almost every case Rb protein was also found in benign cells (endothelial, histiocytes, germinal centre lymphocytes), H and SR cells frequently showed a stronger intensity (see Figure 3) . WB analysis was also undertaken in a small subset of cases of HD, selected on the basis of the availability of frozen tissue, to confirm the IHC data. The results confirm that the labelled protein has a 105-11O kDa molecular weight. Although the intensity of the signal varied from case to case, it was always weaker Unlike the weak relation found in this study between the levels of Ki67 and Rb expression in HD cases as a whole, the group of NLP-HD cases showed a significant and strong relationship between these two proteins. This confirms that NLP-HD is probably a different disease with distinct molecular pathogenesis than the classical forms of HD. Significantly, NLP-HD cases show a similar ratio between these two proteins to that found in benign conditions, suggesting the absence of any Rb disregulation.
This contrasts with classical forms of HD, where the normal relation between Rb and Ki67 has been lost. When analysing this Rb/Ki67 relation, it was possible to identify two main deviations from the normal pattern:
(1) a subset of cases showed undectable (8/130) or low (13/ 130) Rb protein levels in association with a high Ki67 proliferation index. This could indicate a loss of Rb expression in H and SR cells, similar to that described in tumours of different cell lineages. Rb deletion has been described in glioblastomas and CLL (Venter et al., 1991; Kornblau et al., 1994; Stilgenbauer et al., 1993) , mutation in isolated cases of leukaemia and in a wide array of other tumours (Lee et al., 1990; Horowitz et al., 1990 Horowitz et al., , 1991 Ishikawa et al., 1991; Xu et al., 1991a) . The hallmark of all these tumours with Rb disregulation is the absence of Rb protein expression, similar to that found in this small group of cases of HD. Previous cytogenetic studies in untreated HD cases have shown that loss of chromosome 13 was one of the most frequent findings (Tilly et al., 1991; Schouten et al., 1989) . This selective loss of chromosome 13 suggests the possibility of loss of heterozygosity of Rb (located in 13ql4) as a step in HD development, and it may explain the absence of Rb protein expression in a subset of the HD cases analysed in the present study. Loss of Rb expression could also be secondary to gene mutation, or to an altered pattern of transcriptional or translational control of Rb, resulting in reduced expression of the protein (Korblau et al., 1994) .
(2) A second group of cases exhibit an abnormally high Rb/ Ki67 ratio, when compared with PHA-stimulated lymphocytes or reactive lymphoid tissue. This could be interpreted in different ways: an excess of Rb protein could be inducing cell cycle arrest, which is in agreement with the important role of Rb protein in the control of G-S transition. Alternatively, the nuclear accumulation of Rb could be dependent on its interaction with other proteins, which are able to stabilise it. SR cells have been claimed to display large amounts of p53 and MDM2 , two proteins which interact with Rb (Szekely et al., 1993; Xiao et al., 1995) . Some of our findings could point towards some degree of p53-Rb interaction in a group of cases characterised by the presence of a high number of SR cells, since these cases show simultaneous increase in levels of Rb, p53 and Ki67 proteins. It has recently been shown that MDM2 binds to Rb, inactivating it in a way similar to viral proteins (Xiao et al., 1995 (Martinez et al., 1993) and CLL (Kornblau et al., 1994) a significant proportion of cases showed that same anomalous Rb accumulation. In neither case has an explanation been suggested for this finding.
The results of this study point towards an anomalous pattern of expression of Rb in the classical forms of HD. These findings suggest the possibility of undertaking functional studies (EIA adhesion, p16 expression) aimed at improved characterisation of the status of Rb protein, and correlating these findings with the clinical course in HD patients.
